Patent details

Basic Information

Publication number:

EP2321012

PCT Application Number:

US2009053858

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP098086358

PCT Publication Number:

WO2010021928

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ORGANOARSENIC COMPOUNDS AND METHODS FOR THE TREATMENT OF CANCER

French Title of Invention:

COMPOSÉS ORGANOARSÉNIQUES ET MÉTHODES POUR LE TRAITEMENT D'UN CANCER

German Title of Invention:

ORGANOARSENISCHE VERBINDUNGEN UND VERFAHREN ZUR BEHANDLUNG VON KREBS

SPC Number:

Dates

Filing date:

14/08/2009

Grant date:

10/10/2018

EP Publication Date:

18/05/2011

PCT Publication Date:

25/02/2010

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

10/10/2018

EP B1 Publication Date:

10/10/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

14/08/2019

Expiration date:

14/08/2029

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

03/10/2018

 

 

Name:

Solasia Pharma K.K.

Address:

4F, Sumitomo Fudosan Shiba-koen Tower 2-11-1 Shiba-koen Minato-ku, Tokyo 105-0011, Japan (JP)

Inventor

1

Name:

SCHWARTZ, Brian, Eric

Address:

United States (US)

2

Name:

LEWIS, Jonathan

Address:

United States (US)

3

Name:

KOMARNITSKY, Philip, B.

Address:

United States (US)

Priority

Priority Number:

189511 P

Priority Date:

20/08/2008

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/285; A61K 31/455; A61K 31/60; A61K 38/06; A61P 35/00;

Publication

European Patent Bulletin

Issue number:

201841

Publication date:

10/10/2018

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages